# Anna H. Chen

> Anna H. Chen is a Series A investor at Frazier Life Sciences backing Therapeutics. See 2 investments, check sizes, portfolio and contact details. Updated Oct…

- Type: Angel Investor
- Fund: [Frazier Life Sciences](https://shizune.co/investors/profile/frazier-life-sciences-fc2e)
- Location: San Diego, United States
- Total investments: 2
- Last investment: Jan 2026
- Lead investor: 50%
- Last updated: Oct 2026
- LinkedIn: http://www.linkedin.com/in/annahchen

Anna H. Chen is a Series A investor at Frazier Life Sciences in San Diego focused on Therapeutics and Biotechnology. Anna H. Chen

## Contacts

5 contacts available for Anna H. Chen: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/anna-h-chen?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Therapeutics | 2 | 100% |
| Biotechnology | 2 | 100% |
| Health Care | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Series D | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Switzerland | 1 | 50% |
| United States | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| AirNexis Therapeutics | AirNexis Therapeutics develops clinical-stage therapies for chronic obstructive pulmonary disease and other pulmonary conditions. | $200M | Series A | Jan 09, 2026 | https://airnexis.com/ |
| Alentis Therapeutics | Alentis Therapeutics discovers and develops novel medications to treat advanced liver diseases. | $181.4M | Series D | Nov 12, 2024 | https://alentis.ch/ |

2 of 2 investments shown.

## Co-investors
- [Longitude Capital](https://shizune.co/investors/profile/longitude-capital) — VC Fund, 2 deals together
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund, 2 deals together
- [Catalio Capital Management](https://shizune.co/investors/profile/catalio-capital-management) — VC Fund, 1 deal together
- [Enavate Sciences](https://shizune.co/investors/profile/enavate-sciences) — VC Fund, 1 deal together
- [Goldman Sachs Alternatives](https://shizune.co/investors/profile/goldman-sachs-alternatives) — VC Fund, 1 deal together
- [Jeito Capital](https://shizune.co/investors/profile/jeito-capital) — VC Fund, 1 deal together

## About Frazier Life Sciences

VC Fund · Boston, United States

Frazier Life Sciences is a healthcare investment firm that focuses on companies developing novel therapeutics, guiding them from formation to scaling. It engages in early stage venture, late stage venture, private equity, and seed investments, demonstrating a broad commitment to healthcare innovation.

4 contacts available at Frazier Life Sciences.

| Name | Title | Profile |
| --- | --- | --- |
| Anna H. Chen | Principal | https://shizune.co/investors/profile/anna-h-chen |
| Jamie Brush | General Partner and Portfolio Manager | https://shizune.co/investors/profile/jamie-brush |
| Kevin Li | Partner | https://shizune.co/investors/profile/kevin-li-58cc |
| Lauren Mifflin | Vice President of Company Creation | https://shizune.co/investors/profile/lauren-mifflin-dcd2 |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Anna H. Chen invest in?

Anna H. Chen invests primarily in Therapeutics, Biotechnology and Health Care startups, most often at Series A and Series D stage. Most of the 2 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Anna H. Chen?

Public channels for Anna H. Chen include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Anna H. Chen last invest?

The most recent investment recorded for Anna H. Chen closed in Jan 2026. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co